Cargando…

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions

Detalles Bibliográficos
Autores principales: Ko, Tai-Ming, Wu, Jer-Yuarn, Chen, Yuan-Tsong, Shen, Chen-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128421/
http://dx.doi.org/10.1186/2045-7022-4-S3-O4
_version_ 1782330125723893760
author Ko, Tai-Ming
Wu, Jer-Yuarn
Chen, Yuan-Tsong
Shen, Chen-Yang
author_facet Ko, Tai-Ming
Wu, Jer-Yuarn
Chen, Yuan-Tsong
Shen, Chen-Yang
author_sort Ko, Tai-Ming
collection PubMed
description
format Online
Article
Text
id pubmed-4128421
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41284212014-08-14 A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions Ko, Tai-Ming Wu, Jer-Yuarn Chen, Yuan-Tsong Shen, Chen-Yang Clin Transl Allergy Oral Presentation BioMed Central 2014-07-18 /pmc/articles/PMC4128421/ http://dx.doi.org/10.1186/2045-7022-4-S3-O4 Text en Copyright © 2014 Ko et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Ko, Tai-Ming
Wu, Jer-Yuarn
Chen, Yuan-Tsong
Shen, Chen-Yang
A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title_full A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title_fullStr A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title_full_unstemmed A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title_short A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
title_sort prospective study of hla*b-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128421/
http://dx.doi.org/10.1186/2045-7022-4-S3-O4
work_keys_str_mv AT kotaiming aprospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT wujeryuarn aprospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT chenyuantsong aprospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT shenchenyang aprospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT kotaiming prospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT wujeryuarn prospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT chenyuantsong prospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions
AT shenchenyang prospectivestudyofhlab5801genotypinginpreventingallopurinolinducedseverecutaneousadversereactions